Swedish firm to aid UK's cancer treatment delivery

As part of its national cancer program, the United Kingdom's National Health Service (NHS) is currently investing in increased capacity for radiation treatment of cancer.

Photo: Swedish firm to aid UKs cancer treatment delivery

These investments, sponsored by the Department of Health, are providing funding, which is applied for by the NHS hospitals and released in so-called ‘waves’. Recently, the awarded tenders in the 9th wave were announced.

Among these, the Swedish firm Elekta, which specialises in advanced radiation therapy, comprehensive cancer management and non-invasive treatment of brain disorders, has been appointed to deliver six advanced digital linear accelerators for radiation therapy to five UK hospitals: Guy’s Hospital in London, New Cross Hospital in Wolverhampton, Queen Elizabeth Hospital in Birmingham, Poole General Hospital and Southampton General.
In total, the orders are valued at over £6 million.

The hospitals will install Elekta Synergy, fully equipped with precision IMRT, real-time portal imaging and the most clinically advanced 3D X-ray volume imaging for Image Guided Radiation Therapy (IGRT).

In addition to choosing Elekta’s clinical solutions, three of the hospitals will install image-guided treatment management systems from IMPAC Medical Systems, an Elekta company. These will connect treatment planning systems, imaging systems and the radiation therapy delivery equipment - regardless of manufacturer.

01.07.2006

Read all latest stories

Related articles

Photo

The Gamma Knife goes to work in Paris

A major public hospital has become the first in Paris to be equipped with a Gamma Knife, the device that enables the surgeon to operate on the brain with no blade or blood involved.

Photo

Toshiba ASQ delivers hard data on liver fibrosis

Ultrasound presents a promising technology for non-invasive examinations of the abdomen. There is a vast, unmet medical need in the area of liver fibrosis for the clinical assessment of patients with…

Photo

Combining MRI with particle beams

An important step towards live imaging in proton therapy

Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) want to build the world’s first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton…

Related products

Subscribe to Newsletter